TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Fridsbo Pharma AB
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
80
|
269
|
72 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
3
|
200
|
51 |
| EBITDA |
17
|
201
|
51 |
| Total assets |
302
|
326
|
107 |
| Current assets |
248
|
252
|
107 |
| Current liabilities |
72
|
79
|
31 |
| Equity capital |
214
|
230
|
74 |
| - share capital |
4
|
5
|
5 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
70.9%
|
70.6%
|
69.2% |
| Turnover per employee |
80
|
269
|
72 |
| Profit as a percentage of turnover |
3.8%
|
74.3%
|
70.8% |
| Return on assets (ROA) |
1.0%
|
61.3%
|
47.7% |
| Current ratio |
344.4%
|
319.0%
|
345.2% |
| Return on equity (ROE) |
1.4%
|
87.0%
|
68.9% |
| Change turnover |
-167
|
198
|
60 |
| Change turnover % |
-68%
|
279%
|
471% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.